Stocks-NBIX-Neurocrine Biosciences Inc

NBIX Neurocrine Biosciences Inc

119.47 0.93 (0.78%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Neurocrine Biosciences Inc's revenues increased by 31.34% and amounted to 1.49B. Net income increased by 72.43% to 154.50M. Net assets increased by 24.29% to 1.71B and EPS increased from 0.92 to 1.56.
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
Net Profit Margin
Operating Margin
Return On Investment